When V. Sripathy walked into an examination hall in Chennai in November 2023, she was carrying more than a pen and admit card ...
Insilico Medicine will partner with SK Biopharmaceuticals to discover new artificial intelligence (AI)-based drug candidates for disorders affecting the neuroimmune area of the central nervous system ...
Phase 3 PROPEL 3 data published today in NEJM were simultaneously presented at ICCBH in a late-breaking oral presentation; presentation includes new arm span Z-score data showing a statistically ...
Tokyo's approach combines security, economic and diplomatic tools to show regional nations an alternative to the China-US ...
Delhi University has begun UG admission for 2026-27 via the CSAS portal, with a two-phase registration process and 71,600 ...
Over 6 lakh students await the Class 10 Second Board Exam 2026 results. The data from the previous year's Class 10 ...
Texas public schools will require students to read Bible stories under a reading list approved by the state’s education board ...
FDA-positive path for sonelokimab in HS, strong VELA data and BLA timing through 2026, plus more. Click for this MLTX update.
Recently, the NDA for Sumecigrel Capsule (formerly known as Vicagrel), a Class 1 innovative antiplatelet drug developed by ...
MDNA11, as a single agent or in combination with pembrolizumab, continues to demonstrate compelling anti-tumor activity in patients with advanced or metastatic cutaneous melanoma, endometrial cancer a ...
Class, Breakthrough Therapy-Designated Opioid Engineered to Protect Against Oral Overdose ~ ~ SAN DIEGO, CA / ACCESS Newswire / June 26, 2026 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ...
JWST buckyballs have revealed an entirely new set of near-infrared spectral signatures in planetary nebula Tc 1 that Spitzer ...